Calpain inhibitor 2 prevents axonal degeneration of opossum optic nerve fibers

Journal of Neuroscience Research

Volumn 77, Issue 3, 2004, Pages 410-419

  Araújo Couto, Luciana ^a   Narciso, Marcelo Sampaio ^a   Hokoç, Jan Nora ^a   Martinez, Ana Maria Blanco ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Axonal degeneration; Calpain inhibitor; Neuroprotection; Optic nerve; Ultrastructure

Indexed keywords

CALPAIN INHIBITOR 2; CALPASTATIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CALCIUM BLOOD LEVEL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; OPOSSUM; OPTIC NERVE FIBER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME;

ANIMALS; AXONS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; NERVE CRUSH; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; OLIGOPEPTIDES; OPOSSUMS; OPTIC NERVE;

EID: 3242806710     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20170     Document Type: Article

References (55)

1. Banik NL, Powers JM, Hogan EL. 1980. The effects of spinal cord trauma on myelin. J Neuropathol Exp Neurol 39:232-244.
2. Banik NL, Matzelle DD, Wilford GG, Hogan EL. 1997. Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury. Ann N Y Acad Sci 825:120-127.
3. Bartus RT. 1997. The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. Neuroscientist 3:314-327.
4. Becker D, Sadowsky CL, McDonald JW. 2003. Restoring function after spinal cord injury. Neurologist 9:1-15.
5. Carafoli E, Molinari M. 1998. Calpain: a protease in search of a function? Biochem Biophys Res Commun 247:193-203.
6. Chakrabarti AK, Banik NL, Lobo D, Terry E, Hogan E. 1993. Calcium-activated neutral proteinase (calpain) in rat brain during the development: compartmentation and role in myelination. Brain Res Dev Brain Res 71:107-113.
7. Chan SL, Mattson MP. 1999. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58:167-190.
8. Cook RD, Ghetti B, Wisniewski HM. 1974. The pattern of Wallerian degeneration in the optic nerve of newborn kittens: an ultrastructural study. Brain Res 75:261-275.
9. Croall DE, DeMartino GN. 1991. Calcium-activated neutral protease (calpain) system: structure, function and regulation. Physiol Rev 71:813-847.
10. DeMartino GN, Croall DE. 1984. Purification and characterization of a protein inhibitor of calcium-dependent proteases from rat liver. Arch Biochem Biophys 232:713-720.
11. Dezawa M, Adachi-Usami E. 2000. Role of Schwann cells in retinal ganglion cell axon regeneration. Prog Ret Eye Res 19:171-204.
12. George EB, Glass JD, Griffin JW. 1995. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 15:6445-6452.
13. Glass JD, Schryer BL, Griffin JW. 1994. Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse. J Neurochem 62:2472-2475.
14. Guroff G. 1964. A neutral calcium-activated proteinase from the soluble traction of rat brain. J Biol Chem 239:149-155.
15. Happel RD, Smith KP, Banik NL, Powers JM, Hogan EL, Balentine JD. 1981. Calcium-accumulation in experimental spinal cord trauma. Brain Res 211:476-479.
16. Hasegawa M, Rosenbluth J, Ishise J. 1988. Nodal and paranodal structural changes in mouse and rat optic nerve during Wallerian dgeneration. Brain Res 452:345-357.
17. Hokoç JN, Oswaldo-Cruz E. 1978. Quantitative analysis of the opossum's optic nerve: an electron microscope study. J Comp Neurol 178:773-782.
18. Huang Y, Wang KKW. 2001. The calpain family and human disease. Trends Mol Med 7:355-362.
19. Huh GY, Glantz SB, Je S, Morrow JS, Kim JH. 2001. Calpain proteolysis of αII-spectrin in the normal adult human brain. Neurosci Lett 316:41-44.
20. James T, Matzelle DD, Bartus R, Hogan EL, Banik NL. 1998. New inhibitors of calpain prevent degradation of cytoskeleton and myelin proteins in spinal cord in vitro. J Neurosci Res 51:218-222.
21. Li Y, Sauvé Y, Li D, Lund RD, Raisman G. 2003. Transplanted olfactory ensheathing cells promote regeneration of cut adult rat optic nerve axons. J Neurosci Res 23:7783-7788.
22. LoPachin RM, Lehning MN. 1997. Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 143:233-244.
23. Marques SA, Taffarel M, Martinez AMB. 2003. Participation of neurofilament proteins in axonal dark degeneration of rat's optic nerves. Brain Res 696:1-13.
24. Martinez AMB, Canavarro S. 2000. Early myelin breakdown following sural nerve crush: a freeze-fracture study. Braz J Med Biol Res 33:1477-1482.
25. Martinez AMB, Ribeiro LCV. 1998. Ultrastructural localization of calcium in peripheral nerve fibres undergoing Wallerian degeneration: an oxalate-pyroantimonate and X-ray microanalysis study. J Submicrosc Cytol Pathol 30:451-458.
26. Mata M, Kupina N, Fink DJ. 1991. Calpain II in rat peripheral nerve. Brain Res 564:328-331.
27. McDonald WI. 1978. Pathophysiology of nerve and tract conduction. Contemp Clin Neurophysiol 34:385-391.
28. Mellgren RL. 1987. Calcium-dependent proteases: an enzyme system active at cellular membranes? FASEB J 1:110-115.
29. Narciso MS, Hokoç JN, Martinez AMB. 2001. Watery and dark axons in Wallerian degeneration of the opossum's optic nerve: different patterns of cytoskeletal breakdown? An Acad Bras Cienc 73:231-243.
30. Neuberger T, Chakrabarti AK, Russel T, DeVries G, Hogan EL, Banik NL. 1997. Immunolocalization of cytoplasmic and m-calpain isoforms in transfected Schwann cells: I. Effect of treatment with growth factors. J Neurosci Res 47:521-530.
31. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, Siman R. 2001. Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170:27-35.
32. Okano H, Nakamura M, Kaneko S, Iwanami A, Toyama Y. 2003. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 14:191-198.
33. Peters A, Palay SL, Webster HF. 1991. The fine structure of the nervous system-neurons and their supporting cells, 3rd ed. Oxford: Oxford University Press.
34. Posmantur R, Kampfl A, Siman R, Liu SJ, Zhao X, Clifton GL, Haves RL. 1997. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77:875-888.
35. Rami A, Krieglstein J. 1993. Protective effects of calpain inhibitor against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 609:67-70.
36. Ray SK, Wilford GG, Crosby CV, Hogan EL, Banik NL. 1999. Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res 829:18-27.
37. Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. 2000. Increased calpain expression is associated with apoptosis in rat spinal cord injury: Calpain inhibitor provides neuroprotection. Neurochem Res 25:1191-1198.
38. Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. 2001a. Cell death in spinal cord injury (SCI) requires de novo protein system: calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra. Ann N Y Acad Sci 939:436-449.
39. Ray SK, Matzelle DD, Wilford GG, Hogan E., Banik NL. 2001b. Inhibitor of calpain-mediated apoptosis by E-64-d reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats. Brain Res 916:115-126.
40. Ray SP, Neuberger TJ, Deadwyler G, Wilford G, DeVries GH, Banik NL. 2002. Calpain and calpastatin expression in primary oligodendrocyte culture: preferential localization of membrane calpain in cell processes. J Neurosci Res 70:561-569.
41. Ray SK, Hogan EL, Banik NL. 2003. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Rev 42:169-185.
42. Rosenstiel P, Schramm P, Isenmann S, Brecht S, Eickmeier C, Burger E, Herdegen T, Sievers J, Lucius R. 2003. Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo. J Neurotraum 20:297-307.
43. Schlaepfer WW. 1971. Experimental alterations of neurofilaments and neurotubules by calcium and other ions. Exp Cell Res 67:73-80.
44. Schlaepfer WW. 1974. Calcium-induced degeneration of axoplasm in isolated segments of rat peripheral nerve. Brain Res 69:203-215.
45. Schlaepfer WW. 1977. Structural alterations of peripheral nerve induced by the calcium ionophore A23187. Brain Res 136:1-9.
46. Schumacher PA, Siman RG, Fehlings MG. 2000. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 74:1646-1655.
47. Stokes BT, Fox P, Hollinden G. 1983. Extracellular calcium activity in the injured spinal cord. Exp Neurol 80:561-572.
48. Stys PK, Jiang Q. 2002. Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci Lett 328:150-154.
49. 2+ ions. J Biochem 90:275-278.
50. Suzuki K, Imajoh S, Emori Y, Hawashima H, Minami Y, Ohno S. 1987. Calcium activated neutral protease and its endogenous inhibitor: Activation at the cell membrane and biological function. FEBS Lett 220:271-277.
51. Suzuki K, Sorimachi H, Yoshizawa T, Kinbara K, Ishiura S. 1995. Calpain: novel family members, activation and physiological function. Biol Chem Hoppe-Seyler 376:523-529.
52. Waxman SG, Bennett MVL. 1972. Relative conduction velocities of small myelinated and nonmyelinated fibers in the central nervous system. Nat New Biol 238:217-219.
53. Waxman SG, Black JA, Stys PK, Ransom BR. 1992. Ultrastructural concomitants of anoxic injury and early post-anoxic in rat optic nerve. Brain Res 574:105-119.
54. Waxman SG, Black JA, Ransom BR, Stys PK. 1993. Protection of the axonal cytoskeleton in anoxic optic nerve by decrease extracellular calcium. Brain Res 614:137-145.
55. Webster HF, Ames A III. 1965. A reversible and irreversible changes in the fine structure of nervous tissue during oxygen and glucose deprivation. J Cell Biol 26:885-910.